Goodwin, Latham Steer Life Sciences IPOs Totaling $244.5M

Two life sciences companies — clinical-stage, rare diseases- and cancer-focused SpringWorks and migraine-focused Satsuma — raised a combined $244.5 million in a pair of initial public offerings Friday steered by Goodwin...

Already a subscriber? Click here to view full article